FaithAnchor

$Moderna(MRNA.US)

Moderna Has Soared. Is Its Cancer Vaccine Worth the Premium?

Moderna $Moderna(MRNA.US) is reinventing itself beyond COVID-19 vaccines. Its personalised melanoma vaccine, developed with Merck, delivered encouraging Phase 3 results, opening a potential new growth chapter. But after a spectacular rally, investors must ask whether the opportunity justifies the price.

Fundamentals: progress, but losses persist

Moderna reported Q2 2026 revenue of US$145 million and a net loss of US$782 million. Management expects FY2026 revenue growth of up to 10%, with year-end cash projected at US$4.7–5.2 billion. The cancer vaccine could diversify revenue, but regulatory approval, manufacturing costs and commercial uptake remain key hurdles.

Valuation: the biggest concern

At around 32 times trailing sales, Moderna commands a demanding valuation despite continued losses. Traditional price-to-earnings comparisons are unhelpful while earnings remain negative. The market is effectively pricing in substantial future success from its pipeline. Any delay or disappointing commercial outlook could trigger a sharp correction.

How should investors position themselves?

New investors should avoid chasing the rally and consider staged entry only if valuation and risk/reward improve. Existing holders may consider partial profit-taking if the position has grown disproportionately. Long-term investors should monitor regulatory progress, cash burn and evidence of sustainable revenue growth.

Verdict: Moderna’s cancer vaccine offers genuine potential, but scientific success is not the same as investment success. The business needs to convert clinical progress into durable earnings before its valuation becomes easier to justify.

$SK Hynix(SKHY.US)

SK Hynix vs Seagate: Both Beat Earnings. One Flew, One Fell.

SK Hynix surged on explosive earnings, 80% operating margins and booming HBM demand.

Seagate beat earnings too, but slowing shipment growth and sky-high expectations took the shine off.

Same AI party, different expectations at the door.

The lesson? Beating earnings is good. Beating expectations is better.

FaithAnchor — Stay grounded. Stay the course.

$Alphabet(GOOGL.US)

A brutal day for Alphabet. A 12% drop is not something investors can simply brush aside. But does one bad day change the long-term story? I would be more concerned about rising AI spending and whether future returns can justify the cost. Stay the course, but don’t stop questioning what you own.

$StarHub(CC3.SG)

Singapore Telcos: Is Consolidation the Next Investment Opportunity?

For StarHub, the acquisition brings more customers, but the real test is whether they translate into sustainable earnings. With mobile plans competing aggressively on price, subscriber growth alone is not enough. Investors should watch customer retention, integration costs and profit margins.

Singtel remains the more diversified option. Beyond mobile services, it has exposure to regional associates, digital services and data-centre infrastructure. These businesses offer additional growth drivers, although investors should distinguish recurring earnings from one-off gains and special dividends.

StarHub offers a more direct play on consolidation and operational improvements. Its enterprise business and cost-saving initiatives could support a recovery, but investors need to see stronger earnings before assuming the turnaround is on track.

Keppel, meanwhile, offers indirect exposure to M1 through its broader portfolio. Any restructuring could unlock value, but a potential sale remains uncertain.

For long-term investors, Singtel deserves closer attention for its diversified earnings and regional exposure. StarHub may appeal to those willing to take on more execution risk in exchange for potential upside.

The MyRepublic deal is not a game changer. The bigger opportunity lies in whether Singapore’s telcos can turn consolidation into better margins, stronger cash flow and sustainable dividends.

The investment approach: Focus on earnings quality and valuation rather than subscriber numbers or takeover speculation. Even a good business can be a poor investment if the price is too high.

For discussion purposes only. Not financial advice.

$Mapletree Ind Trust(ME8U.SG)

ME8U: A Blue Chip, But At What Cost?

A blue-chip REIT can still lose its shine when the fundamentals turn.

ME8U’s 6.6% DPU decline is a reminder that reputation alone cannot protect distributions. With US leasing under pressure, management needs to rethink where the next dollar of growth comes from.

I would look towards Japan and Singapore’s data-centre markets, but only where tenant demand and returns justify the investment. Equally important is cutting exposure to weaker assets without sacrificing long-term value.

For investors, the question is simple: is this a temporary setback or a structural problem?

Not financial advice.

$Microsoft(MSFT.US)

Microsoft: The Cost of Staying Ahead

Microsoft is offering voluntary buyouts to 60,000 eligible employees. The bigger story isn’t headcount. It’s capital allocation.

AI requires enormous spending, and Microsoft must prove those investments can deliver lasting returns. Reducing costs may help, but severance comes first, savings later.

For shareholders, I’m watching Azure growth, Copilot adoption and free cash flow. Buybacks are a separate decision, not the purpose of this programme.

Microsoft has the resources to lead AI. The question is whether the returns will justify the price of staying ahead.

Not financial advice.

$Meta Platforms(META.US)

Meta wants $40B+ to fund its AI ambitions. Why use non-voting shares instead of piling on more debt?

It protects Zuckerberg’s control and keeps leverage from rising too far.

But shareholders still pay through dilution.

The real question: will the AI investment grow earnings faster than the share count?

$Mattel(MAT.US)

Mattel: Could a Takeover Unlock Value?

Mattel is finding itself in an awkward position. The Barbie maker remains home to some of the world’s strongest toy brands, yet investors are increasingly asking whether the company is better off under new ownership.

A recent CNBC report highlighted growing shareholder pressure for Mattel to consider a sale as growth stalls. That is hardly surprising given the latest numbers.

FY2026 has been mixed. Second-quarter revenue grew 10% to US$1.13 billion, but gross margin slipped to 48.2% while adjusted operating income plunged 59% to US$39 million. Barbie billings fell 16%, although Hot Wheels and action figures continued to perform well. Management expects full-year revenue growth of just 3–6%.

Valuation is where the debate gets interesting. At around US$16 a share, Mattel trades at roughly 12–13 times forward earnings. That does not look demanding, particularly for a company with valuable intellectual property and globally recognised brands. But the discount also reflects slowing growth, weaker profitability and a sizeable debt burden.

Technically, the stock has regained momentum following takeover speculation, but the longer-term trend still needs to prove itself. Chasing the rally could therefore be risky.

For existing shareholders, holding rather than rushing for the exit may make sense while strategic alternatives remain on the table. A sale to a private or strategic investor could potentially unlock value that the public market has failed to recognise.

But there is an important distinction: a takeover premium is not the same as a turnaround. If no credible buyer emerges, investors will once again have to judge Mattel on its underlying earnings.

For shareholders, the real question is whether Mattel is undervalued—or simply a great collection of brands trapped inside a business struggling to grow.

Not financial advice.

Thanks for well documented article that aptly summarises the current market sentiments. @Captain Leo

$Lion-phillip S-Reit(CLR.SG)

Banks → REITs?

The tide may be turning.

Falling U.S. 10-year yields are making Singapore REITs look more attractive again, while banks could see their rate tailwind fade.

For me, it’s less about chasing the rotation and more about watching whether lower yields can become a lasting catalyst for REITs.

Stay anchored.

$Frasers Cpt Tr(J69U.SG)

Frasers Centrepoint Trust (J69U) delivered a strong FY26. DPU reached a record 12.35 cents, NPI grew 15.7% to S$321.7 million and leverage fell to 38.7%.

At around S$2.06, that works out to roughly a 6% yield. Occupancy is also an impressive 99.7%, while 6.6% rental reversions suggest there is still room for income growth.

But would I rush in before the ex-dividend date?

No.

The 6.214-cent 2H distribution looks attractive, but investors should remember that the dividend isn’t free money. Once FCT goes ex-dividend, the unit price should theoretically adjust lower by roughly the distribution amount.

The bigger question is what investors are paying for the underlying REIT.

This is where FCT becomes interesting against CapitaLand Integrated Commercial Trust (C38U).

CICT offers greater diversification across retail, offices and integrated developments. That gives it a broader earnings base, but its office exposure also makes it more sensitive to the commercial property cycle.

FCT is much more focused on suburban retail. That means less diversification, but its malls benefit from recurring daily spending such as groceries, food and essential services. Its 99.7% occupancy and positive rental reversions reinforce that defensive quality.

FCT also has potential growth from AEIs at NEX, Hougang Mall and Causeway Point, while lower financing costs are helping support DPU.

At S$2.06, I don’t think investors need to chase the dividend. I would rather wait for the post-ex-dividend adjustment.

Around S$2.00 becomes more interesting, while S$1.95 or below would provide a better margin of safety, assuming fundamentals remain intact.

Bottom line: CICT offers diversification and scale; FCT offers focused suburban retail exposure, strong occupancy and improving income. I prefer accumulating FCT on weakness rather than buying simply for the dividend.

$Taiwan Semiconductor(TSM.US)

TSMC: AI demand remains powerful, but expectations are rising

TSMC’s latest numbers reinforce why it remains one of the biggest beneficiaries of the AI boom. September revenue jumped 54.6% YoY to NT$511.9 billion, taking 3Q26 revenue to a record NT$1.49 trillion. Jan–Sep revenue is already up 41.1%.

Fundamentally, the story remains compelling. 2Q26 revenue rose 36%, while net profit surged 77.4%. Gross margin reached 67.7%, with 3nm and 5nm together accounting for 63% of wafer revenue. TSMC also maintains a strong balance sheet, providing capacity to fund its aggressive expansion.

The catch is valuation. TSMC trades at roughly 34x trailing earnings, leaving less room for disappointment. Technically, momentum has also cooled, with the stock showing mixed signals after its strong run. This could mean volatility rather than an immediate reversal of the longer-term trend.

Elon Musk ruling out TSMC operating Terafab is a modest sentiment headwind rather than a fundamental blow. TSMC could potentially remain involved through other arrangements, but Musk’s companies building and operating the facility highlights a longer-term risk: major AI players may increasingly pursue greater control over their semiconductor supply chains.

For existing investors, the fundamentals still support staying invested, although taking some profit after a strong run could be sensible for those with an oversized position. New investors may want to stagger entries rather than chase momentum, particularly around upcoming earnings.

The key question is no longer whether AI chip demand exists — it clearly does. The bigger question is whether TSMC’s earnings growth can continue to justify its premium valuation.

Not financial advice.

$SpaceX(SPCX.US)

SpaceX’s reported $4.4B profit is impressive, but the bigger question is how Super Intelligence could reshape Musk’s empire. SpaceX brings computing power, while Tesla offers robotics, autonomy and energy. The synergies are exciting, but I’d rather see them prove the value before merging. Combining businesses doesn’t automatically create shareholder value.